Dark

GILD
Gilead Sciences Inc
stock NASDAQ

At Close

Jan 21, 2026 3:59:59 PM EST

129.16USD+4.044%(+5.02)7,279,695

122.66Bid 133.83Ask 11.17Spread

Pre-market

Jan 20, 2026 8:58:14 AM EST

124.25USD+0.089%(+0.11)0

After-hours

Jan 21, 2026 4:48:30 PM EST

129.30USD+0.108%(+0.14)122,854

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

160.22B

Headquarters

Foster City, California, USA

Industry

Drug Manufacturers-General

Next Earnings

Feb 10, 2026 (19d)

Last Dividend

Dec 15, 20250.790

Last Split

Jan 28, 20132for1

AMGN ALXN CELG VRTX ILMN BIIB JNJ LLY MRK ABBV XLV

GILD Stats

Avg. Vol. 10 Day

6,981,984

Avg. Vol. 30 Day

6,871,073

Employees

10,000

Market Cap

160,221,366,514

Shares Out.

1,240,679,623

On/Off Exchange

53%/47%

6 Month Beta

0.25

1 Year Beta

0.34

2 Year Beta

0.29

3 Year Beta

0.34

52 Week Low

91.84

52 Week High

128.70

SMA50

123.16

SMA200

114.47

1 Week

+4.09%

1 Month

+4.01%

3 Month

+4.08%

6 Month

+19.27%

1 Year

+38.92%

2 Year

+64.66%

5 Year

+92.80%

Profile

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

GILD Stock Summary

Gilead Sciences Inc (NASDAQ:GILD) stock price today is $129.16, and today's volume is 7,279,695. GILD is up 4.044% today. The 30 day average volume is 6,871,073. GILD market cap is 160.22B with 1,240,679,623 shares outstanding.

document.getElementById("W0BKHl").onerror = function(){this.style.display='none';}; .dark-mode .qG81tV{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .qG81tV{ color: #333333; background-color: white; border: 2px solid #333333; }GILDGilead Sciences Incstock NASDAQ

GILD Stock Summary

GILD
Gilead Sciences Inc
stock NASDAQ